Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom
- PMID: 1730708
Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom
Abstract
A peptidyl inhibitor of the high conductance Ca(2+)-activated K+ channels (KCa) has been purified to homogeneity from the venom of the scorpion Androctonus mauretanicus mauretanicus. The peptide has been named kaliotoxin (KTX). It is a single 4-kDa polypeptide chain. Its complete amino acid sequence has been determined. KTX displays sequence homology with other scorpion-derived inhibitors of Ca(2+)-activated or voltage-gated K+ channels: 44% homology with charybdotoxin (CTX), 52% with noxiustoxin (NTX), and 44% with iberiotoxin (IbTX). Electrophysiological experiments performed in identified nerve cells from the mollusc Helix pomatia showed that KTX specifically suppressed the whole cell Ca(2+)-activated K+ current. KTX had no detectable effects on voltage-gated K+ current (delayed rectifier and fast transient A current) or on L-type Ca2+ currents. KTX interacts in a one-to-one way with KCa channels with a Kd of 20 nM. Single channel experiments were performed on high conductance KCa channels excised from the above Helix neurons and from rabbit coeliac ganglia sympathetic neurons. KTX acted exclusively at the outer face of the channel. KTX applied on excised outside-out KCa channels induced a transient period of fast-flicker block followed by a persistent channel blockade. The KTX-induced block was not voltage-dependent which suggests differences in the blockade of KCa channels by KTX and by CTX. Comparison of KTX and CTX sequences leads to the identification of a short amino acid sequence (26-33) which may be implicated in the toxin-channel interaction. KTX therefore appears to be a useful tool for elucidating the molecular pharmacology of the high conductance Ca(2+)-activated K+ channel.
Similar articles
-
Structure-activity studies on scorpion toxins that block potassium channels.Toxicon. 1995 Apr;33(4):425-36. doi: 10.1016/0041-0101(94)00181-7. Toxicon. 1995. PMID: 7570628
-
Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus.J Biol Chem. 1990 Jul 5;265(19):11083-90. J Biol Chem. 1990. PMID: 1694175
-
Synthesis and characterization of kaliotoxin. Is the 26-32 sequence essential for potassium channel recognition?J Biol Chem. 1993 Dec 15;268(35):26302-9. J Biol Chem. 1993. PMID: 8253752
-
Structural basis of voltage-gated K+ channel pharmacology.Trends Pharmacol Sci. 1992 Sep;13(9):359-65. doi: 10.1016/0165-6147(92)90109-j. Trends Pharmacol Sci. 1992. PMID: 1382336 Review.
-
KCa 2.2 (KCNN2): A physiologically and therapeutically important potassium channel.J Neurosci Res. 2023 Nov;101(11):1699-1710. doi: 10.1002/jnr.25233. Epub 2023 Jul 19. J Neurosci Res. 2023. PMID: 37466411 Free PMC article. Review.
Cited by
-
Characterization of a Ca2+-activated K+ current in insulin-secreting murine betaTC-3 cells.J Physiol. 1998 Jun 1;509 ( Pt 2)(Pt 2):355-70. doi: 10.1111/j.1469-7793.1998.355bn.x. J Physiol. 1998. PMID: 9575286 Free PMC article.
-
Peptide Toxins Targeting KV Channels.Handb Exp Pharmacol. 2021;267:481-505. doi: 10.1007/164_2021_500. Handb Exp Pharmacol. 2021. PMID: 34117930 Review.
-
Characterization of a Family of Scorpion Toxins Modulating Ca2+-Activated Cl- Current in Vascular Myocytes.Toxins (Basel). 2022 Nov 10;14(11):780. doi: 10.3390/toxins14110780. Toxins (Basel). 2022. PMID: 36356031 Free PMC article.
-
Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.J Toxicol. 2012;2012:756358. doi: 10.1155/2012/756358. Epub 2012 Jun 4. J Toxicol. 2012. PMID: 22701481 Free PMC article.
-
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.Inflamm Allergy Drug Targets. 2011 Oct;10(5):313-21. doi: 10.2174/187152811797200641. Inflamm Allergy Drug Targets. 2011. PMID: 21824083 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous